NYSE - Nasdaq Real Time Price
USD
Merck & Co., Inc. (MRK)
109.49
-1.46
(-1.32%)
As of 3:13:53 PM EDT. Market Open.
Trade MRK on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for MRK
- Previous Close
110.95 - Open
109.34 - Bid 109.96 x 10000
- Ask 109.99 x 10000
- Day's Range
108.63 - 112.24 - 52 Week Range
73.31 - 125.14 - Volume
9,233,941 - Avg. Volume
10,888,455 - Market Cap (intraday)
270.427B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
15.04 - EPS (TTM)
7.28 - Earnings Date Apr 30, 2026
- Forward Dividend & Yield 3.40 (3.06%)
- Ex-Dividend Date Mar 16, 2026
- 1y Target Est
129.74
Recent News: MRK
View More
Performance Overview: MRK
Trailing total returns as of 4/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
MRK
4.79%
S&P 500 (^GSPC)
5.42%
1-Year Return
MRK
33.18%
S&P 500 (^GSPC)
29.58%
3-Year Return
MRK
3.95%
S&P 500 (^GSPC)
73.07%
5-Year Return
MRK
80.27%
S&P 500 (^GSPC)
72.59%
Earnings Trends: MRK
View MoreAnalyst Insights: MRK
View MoreStatistics: MRK
View MoreValuation Measures
As of 4/29/2026
-
Market Cap
274.03B
-
Enterprise Value
308.81B
-
Trailing P/E
15.24
-
Forward P/E
21.69
-
PEG Ratio (5yr expected)
3.39
-
Price/Sales (ttm)
4.28
-
Price/Book (mrq)
5.21
-
Enterprise Value/Revenue
4.75
-
Enterprise Value/EBITDA
10.93
Financial Highlights
Profitability and Income Statement
-
Profit Margin
28.08%
-
Return on Assets (ttm)
12.04%
-
Return on Equity (ttm)
36.88%
-
Revenue (ttm)
65.01B
-
Net Income Avi to Common (ttm)
18.25B
-
Diluted EPS (ttm)
7.28
Balance Sheet and Cash Flow
-
Total Cash (mrq)
14.57B
-
Total Debt/Equity (mrq)
95.96%
-
Levered Free Cash Flow (ttm)
11.89B
Compare To: MRK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: MRK
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports: MRK
View More-
The Argus High-Yield Model Portfolio
Value stocks -- a market segment that includes high-yield stocks -- outperformed growth stocks in 2022. In 2025, value stocks and growth stocks had similar returns, with growth advancing 13.8% and value returning 13.6%. That's a recent rarity, as for the past decade-plus, the performance record has favored growth. But in 2022, the rollout of COVID-19 vaccines gave a lift to some of the cyclical companies (energy and regional banks), and value stocks outpaced growth stocks that year. While growth stocks led for a few years after that, value stocks are back in the picture as investors rotate out of higher-priced AI growth stocks in search of more reasonable valuations. Value stocks tend to be more resilient in times of market uncertainty and higher volatility as they are less likely to overreact to economic news. In any event, the value sector is the place to achieve income.
-
Raising target price to $130
Merck is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
RatingPrice Target -
Stocks have been volatile on Wednesday, with investors trying to
Stocks have been volatile on Wednesday, with investors trying to interpret the latest labor data. The January jobs report came in better than expected, showing a labor market that is holding steady. Non-farm payrolls were 130,000 and above expectations of 65,000. The unemployment rate ticked down to 4.3% from 4.4%. Meanwhile, the impact of the employment news on possible changes to interest rates remains a focus for Wall Street.
-
Daily – Vickers Top Buyers & Sellers for 02/09/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
